Αρχική World News FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET... World News FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET Fusion-Positive Solid Tumours Από Ogkologos - 2 Σεπτεμβρίου, 2026 115 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the LIBRETTO-001 and LIBRETTO-121 studies Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Misdiagnosis: Her Doctor Dismissed Her Concerns For Months Then Told Her... 2 Ιουνίου, 2020 How serendipity sent this oncologist in search of a cure for... 12 Αυγούστου, 2022 Stressed out – the cancer cells that survive chemotherapy, but at... 29 Απριλίου, 2021 Incidence, Relative Risk and Risk Factors for Chronic Comorbidities in Long-Term... 22 Ιουλίου, 2020 Φόρτωση περισσοτέρων HOT NEWS Foodie Fridays: It’s Cucumber Season! Clinical Benefit and Genomic Features Associations Observed with Pembrolizumab Plus Axitinib... What People With Cancer and Survivors Should Know About Vaping: An... Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk...